SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Semi Equipment Analysis -- Ignore unavailable to you. Want to Upgrade?


To: Proud_Infidel who wrote (27887)1/11/2006 5:09:59 PM
From: Return to Sender  Read Replies (1) | Respond to of 95720
 
An excellent article Brian. A few months back I took a glance at RMBS thinking it was really being overlooked. I should have bought some since I really believed they had a chance to get some good legal rulings.

But my personal wall of worry kept me from acting.

At any rate the market is not rational and it does not price in anything accurately most of the time. That's why we need moving averages and fundamental value measures to make judgement calls.

Even if we are overbought as Bob pointed out the SOX and stock market could continue to become even more overbought in the near term.

Guess we will have to let it happen but I will not be buying into strength.

In the meantime most people will call you a bull and me a bear but neither of us has put a lot of new money to work in a long time to the best of my knowledge.

Good luck to you with all your investments.

RtS



To: Proud_Infidel who wrote (27887)1/11/2006 6:12:50 PM
From: etchmeister  Respond to of 95720
 
LRCX vs NVLS: as one can see the "change" did not develop over time but now it's real. LRCX outperformed its peers and now it shows up on in Cramer's radar and he starts scratching his bald head.
NVLS downgrade could be bullish but I'm afraid NVLS will lag unless NVLS can show progress in CMP.
In case NVLS could deliver (in regards to CMP) it could play catch up but making "recommendation" based on fair value is useless to me.

finance.yahoo.com

Novellus (NVLS:Nasdaq - commentary - research - Cramer's Take) is rated a hold by ValuEngine. This stock is 28.1% undervalued, with fair value at $34.81. The weekly chart profile shows rising momentum and is above its five-week MMA at $24.69.

Novellus has lagged on two brokerage downgrades -- Susquehanna Financial downgraded shares to neutral from positive, and Morgan Stanley downgraded to underweight from equal weight. Long-term investors should consider adding to this holding on weakness to my semiannual value level at $21.23. If you are looking to book profits on strength, consider doing so at my monthly risky level at $26.99.